Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Class A common stock, $0.001 par value
-
Shares outstanding
-
162,474,849
-
Total 13F shares
-
1,297,239
-
Share change
-
+816,262
-
Total reported value
-
$2,062,486
-
Price per share
-
$1.59
-
Number of holders
-
20
-
Value change
-
+$1,299,953
-
Number of buys
-
13
-
Number of sells
-
6
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) as of Q4 2023
As of 31 Dec 2023,
IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,297,239 shares.
The largest 10 holders included
Founders Fund V Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Founders Fund VI Management, LLC, CITADEL ADVISORS LLC, BlackRock Inc., STATE STREET CORP, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, NORTHERN TRUST CORP, and XTX Topco Ltd.
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.